| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/08/2006 | US7087640 Substance with sedative effect |
| 08/08/2006 | US7087619 Method for the treatment of urinary incontinence |
| 08/08/2006 | US7087588 to gastrointestal systems, kidneys |
| 08/08/2006 | US7087587 Blending with adjuvants, compression, coating |
| 08/08/2006 | US7087581 Regeneration of sensitive cells with cell proliferative agents; cyclin-dependent kinase inhibitor; administering antibody |
| 08/08/2006 | US7087578 Administering activated protein c; controlling blood coagulation |
| 08/08/2006 | US7087577 Method of promoting natural bypass |
| 08/08/2006 | US7087263 Polymer coating for drug elution stent; cardiovascular disorders |
| 08/08/2006 | US7087255 Chewing gums that provide breath freshening characteristics |
| 08/08/2006 | US7087249 Nanocrystalline antimicrobial metals (noble metals)formed with atomic disorder are capable of releasing highly active clusters of the antimicrobial metal sufficient to cause microbiocidal effect; anti-inflammatory activity |
| 08/08/2006 | US7087248 Pharmaceutical component based on human parathyroid hormone and a pharmaceutical composition for intranasal administration comprising the component |
| 08/08/2006 | US7087247 Polyesters, method for producing same, and depot medicaments produced from these polyesters |
| 08/08/2006 | US7087246 Controlled release preparation of insulin contains microparticles obtained by microencapsulation of uniform microcystals of insulin using biodegradable polymeric materials. Since the denaturation of insulin that may occur |
| 08/08/2006 | US7087245 Intracelluloar adhesion molecules |
| 08/08/2006 | US7087244 Thermogelling oligopeptide polymers |
| 08/08/2006 | US7087243 Pharmaceutical coating composition and method of use |
| 08/08/2006 | US7087242 Subcoated simulated capsule-like medicament |
| 08/08/2006 | US7087241 Administering a transmucosal formulation, comprising oxybutynin to a subject to provide a plasma area under the curve (AUC) ratio of oxybutynin to an oxybutynin metabolite of from about 0.5:1 to about 5:1, wherein the transmucosal formulation optionally includes a permeation enhancer |
| 08/08/2006 | US7087240 Device and method for the treatment of erectile dysfunction |
| 08/08/2006 | US7087237 Ocular solutions |
| 08/08/2006 | US7087226 Lysin-deficient bacteriophages having reduced immunogenicity |
| 08/08/2006 | US7087222 Introducing an ophthalmically compatible form of a retinoid into the eye of the patient in an amount sufficient to enhance the integrity of the corneal epithelium |
| 08/08/2006 | US7087218 Delivery of diazepam through an inhalation route |
| 08/08/2006 | US7087217 Condensation aerosol for delivery of a drug selected from the group consisting of indomethacin, ketoprofen, celcoxib, rofecoxib, meclofenamic acid, fenoprofen, diflunisal, tolfenamic acid, naproxen, ibuprofen, flurbiprofen and nabumetone |
| 08/08/2006 | US7087216 Condensation aerosol for delivery of a drug selected from the group consisting of zaleplon, zolpidem and zopiclone |
| 08/08/2006 | US7087215 Methods of administering and enhancing absorption of pharmaceutical agents |
| 08/08/2006 | US7086637 Radiofrequency-controlled device for release/sampling of substances |
| 08/08/2006 | US7086532 Titration/compliance pack with increasing doses |
| 08/08/2006 | US7086403 Condom with male genital desensitizer lubricant |
| 08/08/2006 | CA2431368C Intraocular irrigating solution having improved flow characteristics |
| 08/08/2006 | CA2394902C Effervescent histamine h2 antagonist composition |
| 08/08/2006 | CA2348016C Controlled release liquid delivery compositions with low initial drug burst |
| 08/08/2006 | CA2274959C Individually dosed foil-form presentation which decomposes rapidly on contact with liquid and contains an active substance, in particular an aromatic substance |
| 08/08/2006 | CA2206211C A controlled release drug suspension delivery device |
| 08/08/2006 | CA2193503C Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanocrystal formulation |
| 08/08/2006 | CA2188464C Collagen preparation for the controlled release of active substances |
| 08/08/2006 | CA2186895C Process and apparatus for the continuous milling of aerosol pharmaceutical formulations in aerosol propellants |
| 08/08/2006 | CA2110899C Orally administrable therapeutic proteins and method of making |
| 08/03/2006 | WO2006081569A2 Oral osmotic dosage form having a high flux membrane |
| 08/03/2006 | WO2006081517A2 Embolization using poly-4-hydroxybutyrate particles |
| 08/03/2006 | WO2006081364A2 Formulations for injection of catecholic butanes, including ndga compounds, into animals |
| 08/03/2006 | WO2006081363A2 Oral formulations for delivery of catecholic butanes including ndga compounds |
| 08/03/2006 | WO2006081313A1 Hydrophilic beads for use in topical formulations |
| 08/03/2006 | WO2006081279A2 Control of drug release by transient modification of local microenvironments |
| 08/03/2006 | WO2006081147A1 Methods of treating various conditions by administration of sustained release l-arginine |
| 08/03/2006 | WO2006081088A2 Compositions and therapeutic methods utilizing a combination of a protein extravasation inhibitor and an nsaid |
| 08/03/2006 | WO2006080951A2 Targeted and high density drug loaded polymeric materials |
| 08/03/2006 | WO2006080778A1 Solid dispersion comprising tacrolimus and enteric-coated macromolecule |
| 08/03/2006 | WO2006080630A1 Pharmaceutical combination preparation for oral delivery for the treatment of diabetes mellitus |
| 08/03/2006 | WO2006080522A1 Food or drug comprising lactic acid bacterium containing mineral |
| 08/03/2006 | WO2006080508A1 Transdermal absorption preparation, sheet holding transdermal absorption preparation and transdermal absorption preparation holder |
| 08/03/2006 | WO2006080498A1 Tablets containing ornithine hydrochloride |
| 08/03/2006 | WO2006080481A1 Multiple unit oral sustained release preparation and process for production of the same |
| 08/03/2006 | WO2006080452A1 Method for producing fine particle surface-modified with water-soluble substance |
| 08/03/2006 | WO2006080451A1 Process for producing coated fine particle |
| 08/03/2006 | WO2006080312A1 Method for producing adsorptive porous body |
| 08/03/2006 | WO2006080243A1 Coated magnetic particle containing preparation, process for producing the same and diagnostic therapeutic system |
| 08/03/2006 | WO2006080199A1 Patch |
| 08/03/2006 | WO2006080157A1 Molecular aggregate capable of undergoing phase transition by dehydrating condensation and method of phase transition thereof |
| 08/03/2006 | WO2006080118A1 Composition for inhibiting expression of target gene |
| 08/03/2006 | WO2006080029A1 Extended release formulation of levetiracetam |
| 08/03/2006 | WO2006079853A1 Analgesic compositions |
| 08/03/2006 | WO2006079852A1 Chemotherapeutic compositions |
| 08/03/2006 | WO2006079841A1 Nebulizer formulation |
| 08/03/2006 | WO2006079815A1 Stabilised plant extract and its therapeutic use |
| 08/03/2006 | WO2006079796A1 Treatment for mucositis |
| 08/03/2006 | WO2006079722A2 Compositions for freeze-drying proteins |
| 08/03/2006 | WO2006079614A2 Copolyhydroxyalkylglutamines which are functionalised with hydrophobic groups and applications thereof, such as in therapeutics |
| 08/03/2006 | WO2006079496A1 New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance |
| 08/03/2006 | WO2006079409A2 Spray dried compositions |
| 08/03/2006 | WO2006079362A1 Solubilizate of a water-soluble organic acid and method for producing the same |
| 08/03/2006 | WO2006079343A1 A compressed chewing gum table |
| 08/03/2006 | WO2006079342A1 A tooth cleaning kit comprising at least one set of chewing gum pieces. |
| 08/03/2006 | WO2006079216A1 Liposomal compositions for parenteral delivery of agents |
| 08/03/2006 | WO2006079171A1 Aromatherapy system |
| 08/03/2006 | WO2006065991A3 Dispersion for delivering active agents |
| 08/03/2006 | WO2006064503A3 Prolonged transit time of permeability-enhancing drug eluting pill |
| 08/03/2006 | WO2006060727A3 System and method for eeg imaging of cerebral activity using electrode sets |
| 08/03/2006 | WO2006055454A3 Ophthalmic compositions and methods for treating eyes |
| 08/03/2006 | WO2006050072A3 Manufacturing process for liposomal preparations |
| 08/03/2006 | WO2006048865A3 Compositions and kits including dehydrated stinging capsules and methods of producing and using same |
| 08/03/2006 | WO2006046100B1 Pharmaceutical composition of alendronic acid |
| 08/03/2006 | WO2006045532A3 Virosome particles comprising antigens from influenza virus and hepatitis b virus |
| 08/03/2006 | WO2006044421A3 Cardiac safe, rapid medication delivery |
| 08/03/2006 | WO2006042574A3 Sodium ascorbate solubilisate |
| 08/03/2006 | WO2006026469A3 Pharmaceutical formulations of potassium atp channel openers and uses thereof |
| 08/03/2006 | WO2006023130A3 Biodegradable controlled release bioactive agent delivery device |
| 08/03/2006 | WO2006020984A3 Cyclosporin formulations |
| 08/03/2006 | WO2006020365A3 Method for prevention or treatment of inflamatory disease |
| 08/03/2006 | WO2006017540A3 Pilocarpine compositions and methods of use thereof |
| 08/03/2006 | WO2006017336A3 Ceramic structures for prevention of drug diversion |
| 08/03/2006 | WO2006010589A3 Post foaming gel mousse |
| 08/03/2006 | WO2006008512A3 Anti-histaminic composition |
| 08/03/2006 | WO2005113007A3 Powders containing novel oligosaccharide mixtures and methods for producing the same |
| 08/03/2006 | WO2005112889A3 Transmucosal delivery formulations |
| 08/03/2006 | WO2005107719A3 Pharmaceutical composition comprising hydrophobic drug having improved solubility |
| 08/03/2006 | WO2005105278A3 Antisolvent emulsion solidification process |
| 08/03/2006 | WO2005102271A3 Pharmaceutical compositions for glucocorticoid replacement therapy |
| 08/03/2006 | WO2005097195A3 Methods of reducing aggregation of il-1ra |
| 08/03/2006 | WO2005097075A3 Tamper resistant dosage form comprising an adsorbent and an adverse agent |